Atlanta, GA, United States of America

Jie Song

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jie Song

Introduction

Jie Song is a prominent inventor based in Atlanta, GA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of polyoxometalate complexes. With a total of 3 patents to his name, his work is paving the way for new pharmaceutical compositions aimed at managing cancer.

Latest Patents

Jie Song's latest patents focus on polyoxometalate complexes and their applications in the management, treatment, or prevention of cancer. One of his notable disclosures relates to polyoxometalate complexes that comprise polydentate oxygen bridging ligands. These complexes are designed to enhance the efficacy of cancer treatments. Another patent emphasizes the use of these complexes in pharmaceutical compositions, further showcasing their potential in cancer management.

Career Highlights

Jie Song is affiliated with Emory University, where he conducts his research and development. His work has garnered attention for its innovative approach to cancer treatment, and he continues to explore new avenues in this critical area of healthcare.

Collaborations

Jie Song collaborates with esteemed colleagues such as Craig L Hill and Shuming Nie. Their combined expertise contributes to the advancement of research in the field of cancer treatment.

Conclusion

Jie Song's contributions to the field of cancer treatment through his innovative patents highlight the importance of research and development in healthcare. His work at Emory University and collaborations with other experts underscore the collaborative nature of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…